Skip to main content
Journal cover image

A Multicenter Study of Stellate Ganglion Block as a Temporizing Treatment for Refractory Ventricular Arrhythmias.

Publication ,  Journal Article
Chouairi, F; Rajkumar, K; Benak, A; Qadri, Y; Piccini, JP; Mathew, J; Ray, ND; Toman, J; Kautzner, J; Ganesh, A; Sramko, M; Fudim, M
Published in: JACC Clin Electrophysiol
April 2024

BACKGROUND: Ventricular tachycardia (VT) and ventricular fibrillation (VF) are life-threatening conditions and can be refractory to conventional drug and device interventions. Stellate ganglion blockade (SGB) has been described as an adjunct, temporizing intervention in patients with refractory ventricular arrhythmia. We examined the association of SGB with VT/VF in a multicenter registry. OBJECTIVES: This study examined the efficacy of SGB for treatment/temporization of refractory VT/VF. METHODS: The authors present the first analysis from a multicenter registry of patients treated for refractory ventricular arrhythmia at a clinical site in the Czech Republic and the United States. Data were collected between 2016 and 2022. SGB was performed at the bedside by anesthesiologists and/or cardiologists. Outcomes of interest were VT/VF burden and defibrillations at 24 hours before and after SGB. RESULTS: In total, there were 117 patients with refractory ventricular arrhythmias treated with SGB at Duke (n = 49) and the Institute for Clinical and Experimental Medicine (n = 68). The majority of patients were male (94.0%), were White (87.2%), and had an implantable cardioverter-defibrillator (70.1%). The most common etiology of heart disease was ischemic cardiomyopathy (52.1%), and monomorphic VT was the most common morphology (70.1%). Within 24 hours before SGB (0-24 hours), the median episodes of VT/VF were 7.5 (Q1-Q3: 3.0-27.0), and 24 hours after SGB, the median decreased to 1.0 (Q1-Q3: 0.0-4.5; P < 0.001). At 24 hours before SGB, the median defibrillation events were 2.0 (Q1-Q3: 0.0-8.0), and 24 hours after SGB, the median decreased to 0.0 (Q1-Q3: 0.0-1.0; P < 0.001). CONCLUSIONS: In the largest cohort of patients with treatment-refractory ventricular arrhythmia, we demonstrate that SGB use was associated with a reduction in the ventricular arrhythmia burden and need for defibrillation therapy.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JACC Clin Electrophysiol

DOI

EISSN

2405-5018

Publication Date

April 2024

Volume

10

Issue

4

Start / End Page

750 / 758

Location

United States

Related Subject Headings

  • Ventricular Fibrillation
  • United States
  • Treatment Outcome
  • Tachycardia, Ventricular
  • Stellate Ganglion
  • Registries
  • Middle Aged
  • Male
  • Humans
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chouairi, F., Rajkumar, K., Benak, A., Qadri, Y., Piccini, J. P., Mathew, J., … Fudim, M. (2024). A Multicenter Study of Stellate Ganglion Block as a Temporizing Treatment for Refractory Ventricular Arrhythmias. JACC Clin Electrophysiol, 10(4), 750–758. https://doi.org/10.1016/j.jacep.2023.12.012
Chouairi, Fouad, Karuna Rajkumar, Ales Benak, Yawar Qadri, Jonathan P. Piccini, Joseph Mathew, Neil D. Ray, et al. “A Multicenter Study of Stellate Ganglion Block as a Temporizing Treatment for Refractory Ventricular Arrhythmias.JACC Clin Electrophysiol 10, no. 4 (April 2024): 750–58. https://doi.org/10.1016/j.jacep.2023.12.012.
Chouairi F, Rajkumar K, Benak A, Qadri Y, Piccini JP, Mathew J, et al. A Multicenter Study of Stellate Ganglion Block as a Temporizing Treatment for Refractory Ventricular Arrhythmias. JACC Clin Electrophysiol. 2024 Apr;10(4):750–8.
Chouairi, Fouad, et al. “A Multicenter Study of Stellate Ganglion Block as a Temporizing Treatment for Refractory Ventricular Arrhythmias.JACC Clin Electrophysiol, vol. 10, no. 4, Apr. 2024, pp. 750–58. Pubmed, doi:10.1016/j.jacep.2023.12.012.
Chouairi F, Rajkumar K, Benak A, Qadri Y, Piccini JP, Mathew J, Ray ND, Toman J, Kautzner J, Ganesh A, Sramko M, Fudim M. A Multicenter Study of Stellate Ganglion Block as a Temporizing Treatment for Refractory Ventricular Arrhythmias. JACC Clin Electrophysiol. 2024 Apr;10(4):750–758.
Journal cover image

Published In

JACC Clin Electrophysiol

DOI

EISSN

2405-5018

Publication Date

April 2024

Volume

10

Issue

4

Start / End Page

750 / 758

Location

United States

Related Subject Headings

  • Ventricular Fibrillation
  • United States
  • Treatment Outcome
  • Tachycardia, Ventricular
  • Stellate Ganglion
  • Registries
  • Middle Aged
  • Male
  • Humans
  • Female